Literature DB >> 1850030

Inhibitors of poliovirus uncoating efficiently block the early membrane permeabilization induced by virus particles.

M J Almela1, M E González, L Carrasco.   

Abstract

The entry of animal viruses into cells is associated with permeabilization of the infected cells to protein toxins such as alpha-sarcin (C. Fernández-Puentes and L. Carrasco, Cell 20:769-775, 1980). This phenomenon has been referred to as "the early permeabilization by animal viruses" (L. Carrasco, Virology 113:623-629, 1981). A number of inhibitors of poliovirus growth such as WIN 51711 6-(3,4-dichlorophenoxy)-3-(ethylthio)-2-pyridincarbonitrile (DEPC) and Ro 09-0410 specifically block the uncoating step of poliovirus but have no effect on attachment or entry of poliovirus particles into cells. These agents are potent inhibitors of the early permeabilization induced by poliovirus to the toxin alpha-sarcin. Thus, the uncoating of poliovirus is required for the permeabilization of cell membranes to proteins. The increased entry of labeled heparin promoted by virus entry is not blocked by these agents, indicating that poliovirus binds to its receptor and is internalized along with heparin in endosomes in the presence of WIN 51711, DEPC, or Ro 09-0410. We conclude that the delivery to the cytoplasm of some molecules that coenter with virion particles does not take place if the uncoating process is hindered.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1850030      PMCID: PMC240614     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding.

Authors:  C E Fricks; J M Hogle
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

Review 2.  The structure of antiviral agents that inhibit uncoating when complexed with viral capsids.

Authors:  M G Rossmann
Journal:  Antiviral Res       Date:  1989-02       Impact factor: 5.970

3.  Three-dimensional structure of poliovirus at 2.9 A resolution.

Authors:  J M Hogle; M Chow; D J Filman
Journal:  Science       Date:  1985-09-27       Impact factor: 47.728

4.  Structure of a human common cold virus and functional relationship to other picornaviruses.

Authors:  M G Rossmann; E Arnold; J W Erickson; E A Frankenberger; J P Griffith; H J Hecht; J E Johnson; G Kamer; M Luo; A G Mosser
Journal:  Nature       Date:  1985 Sep 12-18       Impact factor: 49.962

Review 5.  Modification of membrane permeability by animal viruses.

Authors:  L Carrasco; M J Otero; J L Castrillo
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

Review 6.  Entry mechanisms of enveloped viruses. Implications for fusion of intracellular membranes.

Authors:  D Hoekstra; J W Kok
Journal:  Biosci Rep       Date:  1989-06       Impact factor: 3.840

Review 7.  Icosahedral RNA virus structure.

Authors:  M G Rossmann; J E Johnson
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

8.  Channels formed by botulinum, tetanus, and diphtheria toxins in planar lipid bilayers: relevance to translocation of proteins across membranes.

Authors:  D H Hoch; M Romero-Mira; B E Ehrlich; A Finkelstein; B R DasGupta; L L Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

9.  Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors.

Authors:  D C Pevear; M J Fancher; P J Felock; M G Rossmann; M S Miller; G Diana; A M Treasurywala; M A McKinlay; F J Dutko
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

10.  Adenovirus-dependent release of 51Cr from KB cells at an acidic pH.

Authors:  P Seth; M C Willingham; I Pastan
Journal:  J Biol Chem       Date:  1984-12-10       Impact factor: 5.486

View more
  9 in total

1.  Antibodies to rotavirus outer capsid glycoprotein VP7 neutralize infectivity by inhibiting virion decapsidation.

Authors:  Juan Ernesto Ludert; Marie Christine Ruiz; Carlos Hidalgo; Ferdinando Liprandi
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

2.  Opening of size-selective pores in endosomes during human rhinovirus serotype 2 in vivo uncoating monitored by single-organelle flow analysis.

Authors:  Marianne Brabec; Daniela Schober; Ernst Wagner; Nora Bayer; Robert F Murphy; Dieter Blaas; Renate Fuchs
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Rotaviruses induce an early membrane permeabilization of MA104 cells and do not require a low intracellular Ca2+ concentration to initiate their replication cycle.

Authors:  M A Cuadras; C F Arias; S López
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Entry of poliovirus into cells does not require a low-pH step.

Authors:  L Pérez; L Carrasco
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

5.  The multifaceted poliovirus 2A protease: regulation of gene expression by picornavirus proteases.

Authors:  Alfredo Castelló; Enrique Alvarez; Luis Carrasco
Journal:  J Biomed Biotechnol       Date:  2011-04-14

6.  Virus-mediated release of endosomal content in vitro: different behavior of adenovirus and rhinovirus serotype 2.

Authors:  E Prchla; C Plank; E Wagner; D Blaas; R Fuchs
Journal:  J Cell Biol       Date:  1995-10       Impact factor: 10.539

7.  Phytochemical analysis and in-vitro anti-African swine fever virus activity of extracts and fractions of Ancistrocladus uncinatus, Hutch and Dalziel (Ancistrocladaceae).

Authors:  Folorunso O Fasina; Oyinlola O Olaokun; Olusola O Oladipo; Margaret M Fasina; Adesoji A Makinde; Livio Heath; Armanda D S Bastos
Journal:  BMC Vet Res       Date:  2013-06-19       Impact factor: 2.741

Review 8.  Modification of membrane permeability by animal viruses.

Authors:  L Carrasco
Journal:  Adv Virus Res       Date:  1995       Impact factor: 9.937

Review 9.  Picornavirus inhibitors.

Authors:  L Carrasco
Journal:  Pharmacol Ther       Date:  1994       Impact factor: 12.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.